Unlearn
San Francisco, US · 11 known investors
Unlearn develops AI-powered digital twins and data analytics tools to optimize clinical trial design and execution for pharmaceutical companies. The company aims to accelerate drug development and bring treatments to patients faster through precision-driven study design.
AI & Machine LearningBiotechDeep TechEnterprise Software
Founders & leadership
CF
Charles FisherinFounder & CEO
AS
Aaron SmithFounder
Investors · 11
8VCAustin · $100K – $50M
Alumni VenturesManchester · $100K – $10M
Basecamp FundManchester · $100K – $10M
DCVC (Data Collective)Palo Alto · $5M – $25M
Eisai Innovation, Inc.San Francisco
Flucas VenturesJupiter · $100K – $5Mvia Ashley Flucas · inferred
Insight PartnersNew York · $120M – $350M
Necessary VenturesSan Francisco · $1M – $2M
Radical VenturesToronto · $1M – $25M
Wittington VenturesToronto
DCVC BioreportedPalo Alto
Founder mafia
2 people who came through Unlearn went on to found or lead other companies.
In the news
Frequently asked questions
- What does Unlearn do?
- Unlearn develops AI-powered digital twins and data analytics tools to optimize clinical trial design and execution for pharmaceutical companies. The company aims to accelerate drug development and bring treatments to patients faster through precision-driven study design.
- Who founded Unlearn?
- Unlearn was founded by Charles Fisher, Aaron Smith.
- Who are Unlearn's investors?
- Unlearn's investors include 8VC, Alumni Ventures, Basecamp Fund, DCVC (Data Collective), Eisai Innovation, Inc., Flucas Ventures, Insight Partners, Necessary Ventures and 3 more.
- Where is Unlearn headquartered?
- Unlearn is headquartered in San Francisco, US.